ProfileGDS5678 / 1438396_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 48% 50% 59% 65% 51% 43% 51% 50% 50% 51% 50% 57% 50% 50% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1967848
GSM967853U87-EV human glioblastoma xenograft - Control 23.1955250
GSM967854U87-EV human glioblastoma xenograft - Control 33.530259
GSM967855U87-EV human glioblastoma xenograft - Control 43.9327865
GSM967856U87-EV human glioblastoma xenograft - Control 53.1656651
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0837343
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3246551
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1922850
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1881950
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2063951
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2021650
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4302457
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1988650
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2012450